Nociceptive vascular reflexes evoked by scorpion venom modulate cardiorespiratory parameters involving vanilloid receptor 1 in anaesthetised rats.
Involvement of vanilloid and 5-HT(3) receptors in the cardiorespiratory reflexes evoked by intra-arterial (i.a.) injection of Mesobuthus tamulus (BT) venom was examined. In anaesthetised rats, blood pressure, respiratory excursions and ECG were recorded for 60min after the injection of venom in the absence or presence of antagonists. Injection of BT venom (1mg/kg, i.a.) produced alterations in respiratory frequency (RF), blood pressure (BP) and heart rate (HR). The changes in RF were manifested as immediate increase (40%) followed by a decrease (40%) and subsequent sustained increase (60%). In case of BP, the increase began around 40s, peaked at 5min (50%) and remained above the initial level subsequently. The bradycardiac response began around 5min which peaked (50% of the initial) around 25min and remained at that level. Thus, exhibiting immediate-tachypnoeic, intermediate-hypertensive and delayed-bradycardiac responses. Pretreatment with lignocaine, blocked the respiratory responses and attenuated the pressor responses evoked by venom. Pretreatment with capsazepine, vanilloid receptor 1 (VR1) antagonist, antagonized all the three parameters of cardiorespiratory responses evoked by venom. Whereas, ondansetron (5-HT(3) antagonist) attenuated the pressor and bradycardiac responses significantly but not the respiratory responses. These observations indicate that the cardiorespiratory changes induced by intra-arterial injection of venom are carried by afferents in addition to somatic nerves, involving mainly VR1 receptors and partially by 5-HT(3) receptors.
Singh
Sanjeev K
SK
Department of Physiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India.
Deshpande
Shripad B
SB
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D001808:Blood Vessels / Q000294:innervation / Q000502:physiology*; D002211:Capsaicin / Q000031:analogs & derivatives / Q000494:pharmacology; D002320:Cardiovascular Physiological Phenomena / Q000187:drug effects*; D004347:Drug Interactions / Q000502:physiology; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D007269:Injections, Intra-Arterial; D008012:Lidocaine / Q000494:pharmacology; D008297:Male; D009619:Nociceptors / Q000187:drug effects* / Q000502:physiology; D051381:Rats; D044406:Receptors, Serotonin, 5-HT3 / Q000187:drug effects / Q000502:physiology; D012018:Reflex / Q000187:drug effects / Q000502:physiology; D012143:Respiratory Physiological Phenomena / Q000187:drug effects*; D012604:Scorpion Venoms / Q000494:pharmacology*; D011984:Sensory Receptor Cells / Q000187:drug effects / Q000502:physiology; D012701:Serotonin / Q000378:metabolism; D050916:TRPV Cation Channels / Q000187:drug effects* / Q000502:physiology; D013997:Time Factors; D017833:Visceral Afferents / Q000187:drug effects / Q000502:physiology
D000889:Anti-Arrhythmia Agents; D044406:Receptors, Serotonin, 5-HT3; D012604:Scorpion Venoms; D050916:TRPV Cation Channels; C494484:TRPV1 receptor; D012701:Serotonin; D008012:Lidocaine; C071423:capsazepine; D002211:Capsaicin